Literature DB >> 10618686

Distribution of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, fludarabine and cytarabine in mice: a whole-body autoradiography study.

S Lindemalm1, J Liliemark, B S Larsson, F Albertioni.   

Abstract

The distribution characteristics of tritiated nucleoside analogs, 2-chloro-2'-deoxyadeonosine (CdA), 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA), 2-fluoroarabinosyladenine (F-ara-A) and cytosine arabinoside (ara-C) were compared in mice using whole-body autoradiography. CdA, CAFdA and F-ara-A have quite similar molecular structures, but they differ substantially in clinical activity as well as the side effects. Eight mice were injected intravenously in couples. One mouse from each pair was killed 20 min postinjection and the other mouse from each pair 4 h after the injection. The distribution of the label was then analyzed by whole-body autoradiography. The distribution of the nucleoside analogs was rapid and uniform. High concentrations were found in highly perfused organs. After 4 h the overall concentration had decreased but relatively high activities were found in the skin for CdA and CAFdA, in the thymus for ara-C and the bone marrow for CdA. Both CdA and CAFdA were found in the brain, but the concentration was surprisingly lower after 4 h for CAFdA, a lipophilic and more stable analog as compared to CdA. There was an uptake of CdA, F-ara-A and CAFdA in the skin. There were signs of retention of ara-C in parts of the thymus. The present investigations indicate that the nucleoside analog transport to the brain in mice is not primarily dependent upon passive diffusion over a lipophilic barrier, but suggestive of a specific transport mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10618686     DOI: 10.1007/bf02785869

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  26 in total

1.  Computer-assisted quantification and image processing of whole-body autoradiograms.

Authors:  R d'Argy; G O Sperber; B S Larsson; S Ullberg
Journal:  J Pharmacol Methods       Date:  1990-11

2.  Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)-adenine in human lymphoblastoid cells.

Authors:  C Xie; W Plunkett
Journal:  Cancer Res       Date:  1995-07-01       Impact factor: 12.701

3.  2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.

Authors:  A Saven; C J Carrera; D A Carson; E Beutler; L D Piro
Journal:  Blood       Date:  1992-08-01       Impact factor: 22.113

4.  [CD7, HLA-DR, CD38 positive acute undifferentiated leukemia with subcutaneous tumor and thymoma].

Authors:  T Doi; S Sakamaki; K Koike; T Matsunaga; D Kobayashi; H Muramatsu; T Sato; N Watanabe; Y Kougo; Y Niitsu
Journal:  Rinsho Ketsueki       Date:  1996-08

5.  Interspecies differences in the kinetic properties of deoxycytidine kinase elucidate the poor utility of a phase I pharmacologically directed dose-escalation concept for 2-chloro-2'-deoxyadenosine.

Authors:  V Reichelová; G Juliusson; T Spasokoukotskaja; S Eriksson; J Liliemark
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

6.  In vivo distribution of 14C-labeled N4-behenoyl-1-beta-D-arabinofuranosylcytosine in mice.

Authors:  S Toyoshima; M Fukuma; Y Seto; H Fujita; K Fukushima; H Tomioka; T Sakurai; Y Sugimoto; T Yagi; T Hoshino; T Sowa
Journal:  Gan       Date:  1981-02

Review 7.  Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies.

Authors:  H M Bryson; E M Sorkin
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

8.  Cladribine in treatment of chronic progressive multiple sclerosis.

Authors:  J C Sipe; J S Romine; J A Koziol; R McMillan; J Zyroff; E Beutler
Journal:  Lancet       Date:  1994-07-02       Impact factor: 79.321

9.  Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice.

Authors:  M Wakamiya; M R Blackburn; R Jurecic; M J McArthur; R S Geske; J Cartwright; K Mitani; S Vaishnav; J W Belmont; R E Kellems
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  Oral 2-chlorodeoxyadenosine in psoriatic arthritis. A preliminary report.

Authors:  B Eibschutz; S M Baird; M H Weisman; D G Amox; M Spellman; D Piacquadio; C J Carrera; D A Carson
Journal:  Arthritis Rheum       Date:  1995-11
View more
  7 in total

1.  Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors.

Authors:  Kyle Jensen; L'Aurelle A Johnson; Pamala A Jacobson; Sonja Kachler; Mark N Kirstein; Jatinder Lamba; Karl-Norbert Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-17       Impact factor: 3.000

2.  RNA Targeting in Acute Myeloid Leukemia.

Authors:  Alessandra Messikommer; Katja Seipel; Stephen Byrne; Peter J M Valk; Thomas Pabst; Nathan W Luedtke
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-12

3.  Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes.

Authors:  J B Langenhorst; C van Kesteren; E M van Maarseveen; T P C Dorlo; S Nierkens; C A Lindemans; M A de Witte; A van Rhenen; R Raijmakers; M Bierings; J Kuball; A D R Huitema; J J Boelens
Journal:  Blood Adv       Date:  2019-07-23

4.  OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.

Authors:  Christina D Drenberg; Alice A Gibson; Stanley B Pounds; Lei Shi; Dena P Rhinehart; Lie Li; Shuiying Hu; Guoqing Du; Anne T Nies; Matthias Schwab; Navjotsingh Pabla; William Blum; Tanja A Gruber; Sharyn D Baker; Alex Sparreboom
Journal:  Cancer Res       Date:  2017-02-16       Impact factor: 12.701

5.  Use of clofarabine for acute childhood leukemia.

Authors:  A Pession; R Masetti; K Kleinschmidt; A Martoni
Journal:  Biologics       Date:  2010-06-24

6.  Superresolution imaging of individual replication forks reveals unexpected prodrug resistance mechanism.

Authors:  Therese Triemer; Alessandra Messikommer; Stella M K Glasauer; Jawad Alzeer; Miriam H Paulisch; Nathan W Luedtke
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

Review 7.  Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism.

Authors:  Nikolaos Tsesmetzis; Cynthia B J Paulin; Sean G Rudd; Nikolas Herold
Journal:  Cancers (Basel)       Date:  2018-07-23       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.